Skip to content

Change in AP at other companies

Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$107.7M+150%
Opko Health logo
Opko HealthOPK
$3.5M-69.5%
Relay Therapeutics, Inc. logo
Relay Therapeutics, Inc.RLAY
$3.67M+206%
Zevra Therapeutics, Inc. logo
Zevra Therapeutics, Inc.ZVRA
-$529K+92.7%
ALN
Alnylam PharmaceuticalsALNY
-$176.03M-11.6%
Intellia Therapeutics logo
Intellia TherapeuticsNTLA
-$1.42M+24.0%

Other financials

Income statement

See full
Revenue$293.0K-84.8%
Operating income-$40.8M+1.9%
Net income-$46.3M-15.8%
EPS (diluted)-$0.57-11.8%

Balance sheet

See full
Cash & equivalents$71.5M+7.5%
Total debt$62.7M-22.5%
Total equity-$58.1M-276%
Total assets$244.7M+9.2%

Cash flow

See full
Operating cash flow$17.8M+148%
CapEx$2.0M+17.4%
Free cash flow$15.8M+141%

Valuation

See full
Market cap$1.07B+31.9%
Enterprise value$1.07B+26.9%
P/S13.5×-10.1×

Profitability

See full
Operating margin-597.9%-207pp
Net margin-615.3%
FCF margin-441.5%-126pp

Returns & leverage

See full
Return on equity-379.5%
Debt / equity27.2×+26.1×
Current ratio0.5×-1.0×

Where this comes from

Reported directly by MeiraGTx Holdings plc in its filing.

Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccountsPayable.

The official record: MeiraGTx Holdings plc’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about MeiraGTx Holdings plc's change in ap.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is MeiraGTx Holdings plc's change in AP?
MeiraGTx Holdings plc (MGTX) reported change in AP of $7.91M in Q1 2026.
How has MeiraGTx Holdings plc's change in AP changed year-over-year?
MeiraGTx Holdings plc's change in AP increased by 358.4% year-over-year, from -$3.06M to $7.91M.
What does change in AP mean?
Increase or decrease in amounts owed to suppliers — a key working capital component affecting operating cash flow.